Fig. 4

Electronic distribution of FMOs for the optimized compounds where a pefloxacin b [Cu(Pf)2(H2O)2].3H2O c [Cu(HPf)(bipy)(NO3)]NO3.2H2O d [Cu(HPf)(phen)(NO3)]NO3.2H2O